$GBCS
SELECTIS HEALTH, INC.

2024 Q4 Form 10-Q Financial Statement

#000149315224046045 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $10.02M
YoY Change 10.73%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $11.19M
YoY Change -2.36%
Operating Profit -$1.172M
YoY Change -51.45%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$435.4K
YoY Change -387.67%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$1.607M
YoY Change -28.96%
Net Earnings / Revenue -16.04%
Basic Earnings Per Share -$0.52
Diluted Earnings Per Share -$0.52
COMMON SHARES
Basic Shares Outstanding 3.067M shares 3.067M shares
Diluted Shares Outstanding 3.067M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.823M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $1.904M
Other Receivables
Total Short-Term Assets $3.533M
YoY Change -40.27%
LONG-TERM ASSETS
Property, Plant & Equipment $28.48M
YoY Change -16.84%
Goodwill $1.077M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $30.40M
YoY Change -16.55%
TOTAL ASSETS
Total Short-Term Assets $3.533M
Total Long-Term Assets $30.40M
Total Assets $33.93M
YoY Change -19.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $12.76M
YoY Change 26.01%
Total Short-Term Liabilities $20.20M
YoY Change 37.24%
LONG-TERM LIABILITIES
Long-Term Debt $18.47M
YoY Change -28.77%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $18.47M
YoY Change -28.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.20M
Total Long-Term Liabilities $18.47M
Total Liabilities $38.76M
YoY Change -6.96%
SHAREHOLDERS EQUITY
Retained Earnings -$19.62M
YoY Change 39.07%
Common Stock $153.4K
YoY Change 0.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.834M
YoY Change
Total Liabilities & Shareholders Equity $33.93M
YoY Change -19.86%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$1.607M
YoY Change -28.96%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei City Area Code
CityAreaCode
(720)
dei Local Phone Number
LocalPhoneNumber
680-0808
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7510881 usd
CY2024Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
844429 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
269197 usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0000727346
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-15415
dei Entity Registrant Name
EntityRegistrantName
Selectis Health, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0340206
dei Entity Address Address Line1
EntityAddressAddressLine1
8480 E Orchard Rd
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste 4900
dei Entity Address City Or Town
EntityAddressCityOrTown
Greenwood Village
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3067059 shares
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1904432 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2091536 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
644353 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1380570 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
3533158 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
4956705 usd
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
838223 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
820124 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28480891 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33817718 usd
CY2024Q3 us-gaap Goodwill
Goodwill
1076908 usd
CY2023Q4 us-gaap Goodwill
Goodwill
1076908 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6481446 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6045365 usd
CY2024Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
53100 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
30600 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
455711 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
524704 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
12761635 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
11170100 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
20196181 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18146065 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
0 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
30663 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
18465042 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25176435 usd
CY2024Q3 us-gaap Security Deposit Liability
SecurityDepositLiability
101750 usd
CY2023Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
312750 usd
CY2024Q3 us-gaap Liabilities
Liabilities
38762973 usd
CY2023Q4 us-gaap Liabilities
Liabilities
43635250 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3067059 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3067059 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
153352 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
153352 usd
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2024Q3 GBCS Income From Employee Retention Credits
IncomeFromEmployeeRetentionCredits
usd
GBCS Income From Employee Retention Credits
IncomeFromEmployeeRetentionCredits
usd
CY2023Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80111
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2023Q4 us-gaap Assets
Assets
40671455 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3067059 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3067059 shares
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13852028 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13852028 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19615173 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17745175 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-4833793 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-2963795 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
33929180 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40671455 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10016416 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9045456 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29093623 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27579941 usd
CY2024Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
7573735 usd
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
7698266 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
23633389 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2395897 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3133797 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6982262 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1044665 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1167332 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
374118 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
357868 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1207247 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1235446 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
11188179 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
11459128 usd
us-gaap Operating Expenses
OperatingExpenses
31725560 usd
us-gaap Operating Expenses
OperatingExpenses
33547048 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1171763 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2413672 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2631937 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5967107 usd
CY2024Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3774 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
29133 usd
CY2024Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
471356 usd
CY2023Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
408211 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1662037 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1493923 usd
GBCS Income From Employee Retention Credits
IncomeFromEmployeeRetentionCredits
6866759 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2112143 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
39771 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
43325 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
363466 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
256347 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-435359 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
784439 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5629183 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2262332 usd
us-gaap Net Income Loss
NetIncomeLoss
-1847498 usd
us-gaap Net Income Loss
NetIncomeLoss
-337924 usd
CY2024Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
7500 usd
CY2023Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
7500 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
22500 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
22500 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1614622 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2269832 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1869998 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-360424 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.60
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3067059 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3067059 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3054587 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3054587 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3067059 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3067059 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3054587 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3054587 shares
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-3219171 usd
CY2024Q3 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
7500 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1607122 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2862243 usd
CY2023Q3 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
7500 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3054587 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3067059 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3054587 shares
CY2024Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
GBCS Other Income From Partial Settlement Of Debt
OtherIncomeFromPartialSettlementOfDebt
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
GBCS Increase Decrease In Employee Retention Credit Receivables
IncreaseDecreaseInEmployeeRetentionCreditReceivables
usd
us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
usd
GBCS Proceeds From Debt Discount Warrants
ProceedsFromDebtDiscountWarrants
usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
usd
GBCS Payoff Of Secured Fixed Rate Mortgage Loan
PayoffOfSecuredFixedRateMortgageLoan
usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q3 us-gaap Cash
Cash
984373 usd
CY2023Q4 us-gaap Cash
Cash
1484599 usd
CY2024Q3 us-gaap Assets
Assets
33929180 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
22491386 usd
CY2023Q3 GBCS Income From Employee Retention Credits
IncomeFromEmployeeRetentionCredits
516226 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
151340 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1607122 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-4833793 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
84352 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2262332 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
676763 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-2963795 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
22500 usd
us-gaap Net Income Loss
NetIncomeLoss
-1847498 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-4833793 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
952835 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
952835 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
22500 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
84352 usd
us-gaap Net Income Loss
NetIncomeLoss
-337924 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
676763 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
676763 usd
us-gaap Net Income Loss
NetIncomeLoss
-1847498 usd
us-gaap Net Income Loss
NetIncomeLoss
-337924 usd
GBCS Other Income From Partial Settlement Of Debt
OtherIncomeFromPartialSettlementOfDebt
50000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1207247 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1235446 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
99656 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
343326 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1044665 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1167332 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
2112143 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
857561 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
291075 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-589477 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-798764 usd
GBCS Increase Decrease In Employee Retention Credit Receivables
IncreaseDecreaseInEmployeeRetentionCreditReceivables
1257980 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
436081 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
771002 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
39000 usd
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
12000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1401076 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2390891 usd
us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
2484800 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26227 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27891 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2458573 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27891 usd
us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
371683 usd
us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
501006 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
250000 usd
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
2161307 usd
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
2286679 usd
GBCS Proceeds From Debt Discount Warrants
ProceedsFromDebtDiscountWarrants
84352 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
6900 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1539624 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1708221 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-482127 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
654779 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2304723 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2416600 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1822596 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3071379 usd
us-gaap Interest Paid Net
InterestPaidNet
1555703 usd
us-gaap Interest Paid Net
InterestPaidNet
1150597 usd
CY2024Q3 us-gaap Cash
Cash
984373 usd
CY2023Q3 us-gaap Cash
Cash
1971732 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
838223 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1099647 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1822596 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3071379 usd
GBCS Dividends Declared On Series D Preferred Stock
DividendsDeclaredOnSeriesDPreferredStock
22500 usd
GBCS Dividends Declared On Series D Preferred Stock
DividendsDeclaredOnSeriesDPreferredStock
22500 usd
GBCS Payoff Of Secured Fixed Rate Mortgage Loan
PayoffOfSecuredFixedRateMortgageLoan
3736029 usd
GBCS Financing Of Insurance Premiums
FinancingOfInsurancePremiums
429939 usd
GBCS Financing Of Insurance Premiums
FinancingOfInsurancePremiums
817749 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1401076 usd
CY2024Q3 GBCS Working Capital Deficit
WorkingCapitalDeficit
-16700000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1607122 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2262332 usd
us-gaap Net Income Loss
NetIncomeLoss
-1847498 usd
us-gaap Net Income Loss
NetIncomeLoss
-337924 usd
CY2024Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
7500 usd
CY2023Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
7500 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
22500 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
22500 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1614622 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2269832 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1869998 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-360424 usd
CY2024Q3 GBCS Net Income Loss Attributable To Diluted Gross
NetIncomeLossAttributableToDilutedGross
-1607122 usd
CY2023Q3 GBCS Net Income Loss Attributable To Diluted Gross
NetIncomeLossAttributableToDilutedGross
-2262332 usd
GBCS Net Income Loss Attributable To Diluted Gross
NetIncomeLossAttributableToDilutedGross
-1847498 usd
GBCS Net Income Loss Attributable To Diluted Gross
NetIncomeLossAttributableToDilutedGross
-337924 usd
CY2024Q3 GBCS Preferred Stock Dividends And Other Adjustments Diluted
PreferredStockDividendsAndOtherAdjustmentsDiluted
7500 usd
CY2023Q3 GBCS Preferred Stock Dividends And Other Adjustments Diluted
PreferredStockDividendsAndOtherAdjustmentsDiluted
7500 usd
GBCS Preferred Stock Dividends And Other Adjustments Diluted
PreferredStockDividendsAndOtherAdjustmentsDiluted
22500 usd
GBCS Preferred Stock Dividends And Other Adjustments Diluted
PreferredStockDividendsAndOtherAdjustmentsDiluted
22500 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1614622 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2269832 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1869998 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-360424 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3067059 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3067059 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3054587 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3067059 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3054587 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3067059 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3054587 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3067059 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3054587 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.60
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
42977214 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
49256168 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12936323 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13878450 usd
CY2024Q3 GBCS Impairment Property Plant And Equipment
ImpairmentPropertyPlantAndEquipment
1560000 usd
CY2023Q4 GBCS Impairment Property Plant And Equipment
ImpairmentPropertyPlantAndEquipment
1560000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28480891 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
33817718 usd
us-gaap Depreciation
Depreciation
1207247 usd
us-gaap Depreciation
Depreciation
1235446 usd
CY2024Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
32582388 usd
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
37801902 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
455711 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
555367 usd
CY2024Q3 GBCS Debt Longterm And Shortterm Combined Net Amount
DebtLongtermAndShorttermCombinedNetAmount
32126677 usd
CY2023Q4 GBCS Debt Longterm And Shortterm Combined Net Amount
DebtLongtermAndShorttermCombinedNetAmount
37246535 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
12761635 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
11170100 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
18465042 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
25176435 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3067059 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3067059 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
30000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.00
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
30000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.00

Files In Submission

Name View Source Status
0001493152-24-046045-index-headers.html Edgar Link pending
0001493152-24-046045-index.html Edgar Link pending
0001493152-24-046045.txt Edgar Link pending
0001493152-24-046045-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
gbcs-20240930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
gbcs-20240930_cal.xml Edgar Link unprocessable
gbcs-20240930_def.xml Edgar Link unprocessable
gbcs-20240930_lab.xml Edgar Link unprocessable
gbcs-20240930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable